Emodin reverses leukemia multidrug resistance by competitive inhibition and downregulation of P-glycoprotein

Development of multidrug resistance (MDR) is a continuous clinical challenge partially due to the overexpression of P-glycoprotein (P-gp) for chronic myelogenous leukemia (CML) patients. Herein, we evaluated the inhibitory potency of emodin, a natural anthraquinone derivative isolated from Rheum pal...

全面介紹

Na minha lista:
書目詳細資料
發表在:PLoS One
Main Authors: Min, Hongping, Niu, Miaomiao, Zhang, Weilin, Yan, Jia, Li, Jiachang, Tan, Xiying, Li, Bo, Su, Mengxiang, Di, Bin, Yan, Fang
格式: Artigo
語言:Inglês
出版: Public Library of Science 2017
主題:
Research Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5679605/
https://ncbi.nlm.nih.gov/pubmed/29121121
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0187971
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍